|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
ABROCITINIB |
D11AH08 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005452 |
09-12-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
TECOVIRIMAT |
J05AX24 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005248 |
06-01-2022 |
VALID
|
|
AVACOPAN |
L04AJ05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
VOXELOTOR |
B06AX03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004869 |
14-02-2022 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
INEBILIZUMAB |
L04AG10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
RELUGOLIX |
L02BX04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
CAPMATINIB |
L01EX17 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
DE
|
I
|
14-11-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MITAPIVAT |
B06AX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B02BD16 |
DE
|
POM
|
|
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
